BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35383352)

  • 21. Growth hormone affects gene expression and proliferation in human prostate cancer cells.
    Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
    Int J Androl; 2011 Apr; 34(2):124-37. PubMed ID: 20546049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance.
    Muller AF; Janssen JA; Hofland LJ; Lamberts SW; Bidlingmaier M; Strasburger CJ; van der Lely AJ
    J Clin Endocrinol Metab; 2001 Feb; 86(2):590-3. PubMed ID: 11158013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro effects of somatostatin on the growth hormone-insulin-like growth factor axis in orange-spotted grouper (Epinephelus coioides).
    Wang B; Jia J; Yang G; Qin J; Zhang C; Zhang Q; Sun C; Li W
    Gen Comp Endocrinol; 2016 Oct; 237():1-9. PubMed ID: 26526981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression.
    Minoia M; Gentilin E; Molè D; Rossi M; Filieri C; Tagliati F; Baroni A; Ambrosio MR; degli Uberti E; Zatelli MC
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E907-16. PubMed ID: 22442272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2.
    Barclay JL; Kerr LM; Arthur L; Rowland JE; Nelson CN; Ishikawa M; d'Aniello EM; White M; Noakes PG; Waters MJ
    Mol Endocrinol; 2010 Jan; 24(1):204-17. PubMed ID: 19884384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The exon 3-deleted growth hormone receptor: molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions.
    Filopanti M; Giavoli C; Grottoli S; Bianchi A; De Marinis L; Ghigo E; Spada A
    J Endocrinol Invest; 2011 Dec; 34(11):861-8. PubMed ID: 22322534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
    Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
    Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of growth hormone and nandrolone decanoate alters mRNA expression of the GABAB receptor subunits as well as of the GH receptor, IGF-1, and IGF-2 in rat brain.
    Grönbladh A; Johansson J; Nyberg F; Hallberg M
    Growth Horm IGF Res; 2014; 24(2-3):60-6. PubMed ID: 24480470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone receptor expression and function in pituitary adenomas.
    Clausen LR; Kristiansen MT; Rasmussen LM; Billestrup N; Blaabjerg O; Ledet T; Jørgensen JO
    Clin Endocrinol (Oxf); 2004 May; 60(5):576-83. PubMed ID: 15104560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone potentiates 17β-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling.
    Felice DL; El-Shennawy L; Zhao S; Lantvit DL; Shen Q; Unterman TG; Swanson SM; Frasor J
    Endocrinology; 2013 Sep; 154(9):3219-27. PubMed ID: 23782942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes.
    Jux C; Leiber K; Hügel U; Blum W; Ohlsson C; Klaus G; Mehls O
    Endocrinology; 1998 Jul; 139(7):3296-305. PubMed ID: 9645706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth Axis
    Xie RL; Liang R; Luo YY; Ruan ZH; Li YF; Liu WS
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice.
    Takahara K; Ibuki N; Ghaffari M; Tearle H; Ong CJ; Azuma H; Gleave ME; Pollak M; Cox ME
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):239-47. PubMed ID: 23689346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth.
    Wang J; Zhou J; Cheng CM; Kopchick JJ; Bondy CA
    J Endocrinol; 2004 Feb; 180(2):247-55. PubMed ID: 14765976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).
    Zhang Y; Gc S; Patel SB; Liu Y; Paterson AJ; Kappes JC; Jiang J; Frank SJ
    Mol Cell Endocrinol; 2019 Jul; 492():110445. PubMed ID: 31100495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical localisation of growth hormone (GH), GH receptor (GHR), insulin-like growth factor I (IGF-I) and type I IGF-I receptor, and gene expression of GH and GHR in rat pre-antral follicles.
    Zhao J; Taverne MA; van der Weijden GC; Bevers MM; van den Hurk R
    Zygote; 2002 Feb; 10(1):85-94. PubMed ID: 11964096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly.
    Bianchi A; Mazziotti G; Tilaro L; Cimino V; Veltri F; Gaetani E; Pecorini G; Pontecorvi A; Giustina A; De Marinis L
    Pituitary; 2009; 12(3):196-9. PubMed ID: 19089622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GH receptor blocker administration and muscle-tendon collagen synthesis in humans.
    Nielsen RH; Doessing S; Goto K; Holm L; Reitelseder S; Agergaard J; Schjerling P; Flyvberg A; Kjaer M
    Growth Horm IGF Res; 2011 Jun; 21(3):140-5. PubMed ID: 21498100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment.
    Sustarsic EG; Junnila RK; Kopchick JJ
    Biochem Biophys Res Commun; 2013 Nov; 441(1):144-50. PubMed ID: 24134847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
    Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
    Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.